UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Repurposing the Hedgehog pathway inhibitor, BMS-833923, as a phosphatidylglycerol-selective membrane-disruptive colistin adjuvant against ESKAPE pathogens Journal article
Zhang,Nian, Shan,Wenying, Gao,Liangliang, Kou,Si Hoi, Lu,Chang, Yang,Huilin, Peng,Bo, Tam,Kin Yip, Lee,Leo Tsz On, Zheng,Jun. Repurposing the Hedgehog pathway inhibitor, BMS-833923, as a phosphatidylglycerol-selective membrane-disruptive colistin adjuvant against ESKAPE pathogens[J]. International Journal of Antimicrobial Agents, 2023, 62(3), 106888.
Authors:  Zhang,Nian;  Shan,Wenying;  Gao,Liangliang;  Kou,Si Hoi;  Lu,Chang; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:4.9/5.6 | Submit date:2023/08/03
Antibiotic Resistance  Colistin Adjuvant  Drug Repurposing  Eskape  Membrane-disruptive Drug  
LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation Journal article
Sun, Jian, Jin, Tongzhu, Niu, Zhihui, Guo, Jiayu, Guo, Yingying, Yang, Ruoxuan, Wang, Qianqian, Gao, Huiying, Zhang, Yuhan, Li, Tianyu, He, Wenxin, Li, Zhixin, Ma, Wenchao, Su, Wei, Li, Liangliang, Fan, Xingxing, Shan, Hongli, Liang, Haihai. LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation[J]. Acta Pharmaceutica Sinica B, 2022, 12(9), 3602-3617.
Authors:  Sun, Jian;  Jin, Tongzhu;  Niu, Zhihui;  Guo, Jiayu;  Guo, Yingying; et al.
Favorite | TC[WOS]:16 TC[Scopus]:17  IF:14.7/14.1 | Submit date:2023/01/30
Ctnnb1  Extracellular Matrix  Fibroblast  Idiopathic Pulmonary Fibrosis  Lncrna Dach1  Myofibroblast  Proliferation  Srsf1  
Sanguinarine synergistically potentiates aminoglycoside-mediated bacterial killing Journal article
Lu, Chang, Zhang, Nian, Kou, Sihoi, Gao, Liangliang, Peng, Bo, Dai, Yunlu, Zheng, Jun. Sanguinarine synergistically potentiates aminoglycoside-mediated bacterial killing[J]. Microbial Biotechnology, 2022, 15(7), 2055 - 2070.
Authors:  Lu, Chang;  Zhang, Nian;  Kou, Sihoi;  Gao, Liangliang;  Peng, Bo; et al.
Favorite | TC[WOS]:16 TC[Scopus]:16  IF:4.8/5.8 | Submit date:2022/05/17